A Special Report on the top five trends redefining the way healthcare stakeholders look at long-term healthcare access sustainability in the region from Roshel Jayasundera, director, Global Consulting, Axios International.
Over the last decade, Southeast Asia’s healthcare landscape has evolved considerably. This has been chiefly led by the seismic shifts in disease patterns and population trends, the increase in universal healthcare coverage plans as well as the rise of scientific breakthroughs in healthcare.
However, the landscape has also been defined by the ongoing attempts by stakeholders to overcome persistent gaps within the healthcare access ecosystem – the growth of which has not kept pace with the region’s broader socio-economic development. These realities were put under the microscope during the ongoing COVID-19 pandemic, especially in terms of access.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze